Are we really active in the prevention of obesity and type 2 diabetes at the community level?

M Uusitupa, J Tuomilehto, P Puska - Nutrition, Metabolism and …, 2011 - Elsevier
The prevalence of type 2 diabetes is increasing rapidly worldwide. Much of this increase in
type 2 diabetes epidemic is related to the increase in obesity. There is now firm evidence …

[HTML][HTML] Cost effectiveness of type 2 diabetes screening: A systematic review

B Najafi, F Farzadfar, H Ghaderi… - Medical journal of the …, 2016 - ncbi.nlm.nih.gov
Background: Although studies reported diabetes mellitus screening cost effective, the mass
screening for type2 diabetes remains controversial. In this study we reviewed the recently …

Effect of screening for type 2 diabetes on population‐level self‐rated health outcomes and measures of cardiovascular risk: 13‐year follow‐up of the Ely cohort

M Rahman, RK Simmons, SH Hennings… - Diabetic …, 2012 - Wiley Online Library
Diabet. Med. 29, 886–892 (2012) Abstract Aims There is continuing uncertainty regarding
the overall net benefits of population‐based screening for Type 2 diabetes. We compared …

Reducing frictions in healthcare access: the actionhealth NYC experiment for undocumented immigrants

J Gruber, A Sabety, R Sood, JY Bae - 2022 - nber.org
ABSTRACT In 2016, New York City designed and implemented an intervention reducing
frictions in accessing safety-net care: randomly making initial primary care appointments for …

Screening for hyperglycemia in the developing world: rationale, challenges and opportunities

JB Echouffo-Tcheugui, M Mayige, AO Ogbera… - Diabetes research and …, 2012 - Elsevier
BACKGROUND: The prevalence of diabetes and prediabetes are increasingly high in
developing countries, where detection rates remain very low. This manuscript discusses the …

Bridging Gaps in Diabetic Nephropathy Care: A Narrative Review Guided by the Lived Experiences of Patient Partners

W Beaubien-Souligny, S Leclerc… - Canadian journal of …, 2022 - journals.sagepub.com
Purpose of review: Diabetes affects almost a 10th of the Canadian population, and diabetic
nephropathy is one of its main complications. It remains a leading cause of kidney failure …

A Markov decision process for modeling adverse drug reactions in medication treatment of type 2 diabetes

M Eghbali-Zarch… - Proceedings of the …, 2019 - journals.sagepub.com
Type 2 diabetes has an increasing prevalence and high cost of treatment. The goal of type 2
diabetes treatment is to control patients' blood glucose level by pharmacological …

Intensified glucose control in type 2 diabetes—whose agenda?

JS Yudkin, B Richter, EAM Gale - The Lancet, 2011 - thelancet.com
How solid is the evidence for glucose lowering in people with diabetes? The Diabetes
Control and Complications Trial showed that glucose control slows progression of …

Reconsidering the age thresholds for type II diabetes screening in the US

S Chung, KMJ Azar, M Baek, DS Lauderdale… - American journal of …, 2014 - Elsevier
Background Type II diabetes and its complications can sometimes be prevented, if identified
and treated early. One fifth of diabetics in the US remain undiagnosed. Commonly used …

[HTML][HTML] Developing the quantitative histopathology image ontology (QHIO): a case study using the hot spot detection problem

MN Gurcan, J Tomaszewski, JA Overton… - Journal of biomedical …, 2017 - Elsevier
Interoperability across data sets is a key challenge for quantitative histopathological
imaging. There is a need for an ontology that can support effective merging of pathological …